Triple

T412175

Position	Surface form	Disambiguated ID	Type / Status
Subject	National Institute on Drug Abuse	`E9512`	entity
Predicate	operates	`P24`	FINISHED
Object	NIDA Drug Supply Program The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.	`E53471`	NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini

Instruction

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Input

Phrase: NIDA Drug Supply Program | Statement: [National Institute on Drug Abuse, operates, NIDA Drug Supply Program]

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: NIDA Drug Supply Program
Context triple: [National Institute on Drug Abuse, operates, NIDA Drug Supply Program]

A. NIDA International Program
NIDA International Program is a global initiative of the U.S. National Institute on Drug Abuse that fosters international collaboration in drug abuse research, training, and policy.
B. National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
C. Global Drug Facility
The Global Drug Facility is an international initiative that improves worldwide access to quality-assured tuberculosis medicines and diagnostics, particularly in low- and middle-income countries.
D. Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
E. Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NEDg Description generation gpt-5.1

Instruction

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Input

Entity: NIDA Drug Supply Program
Triple: [National Institute on Drug Abuse, operates, NIDA Drug Supply Program]

Generated description

The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: NIDA Drug Supply Program
Target entity description: The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.

A. NIDA International Program
NIDA International Program is a global initiative of the U.S. National Institute on Drug Abuse that fosters international collaboration in drug abuse research, training, and policy.
B. National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
C. Global Drug Facility
The Global Drug Facility is an international initiative that improves worldwide access to quality-assured tuberculosis medicines and diagnostics, particularly in low- and middle-income countries.
D. Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
E. Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step	Stage	Batch ID	Status	When
creating	Elicitation	`batch_69a2e80111fc8190961d5b7c6154123f`	completed	Feb. 28, 2026, 1:05 p.m.
NER	Named-entity recognition	`batch_69a2ecdafa2481908111accc918ff2e8`	completed	Feb. 28, 2026, 1:25 p.m.
NED1	Entity disambiguation (via context triple)	`batch_69a42a1498808190a3639dedfe8ab5ea`	completed	March 1, 2026, 11:59 a.m.
NEDg	Description generation	`batch_69a42a69729881909d2a549e8601b66a`	completed	March 1, 2026, noon
NED2	Entity disambiguation (via description)	`batch_69a42ac5d8f481908b59c72cf3698021`	completed	March 1, 2026, 12:02 p.m.

Created at: Feb. 28, 2026, 1:09 p.m.